Kilroy Announces Leadership Transition - Seite 2

“I am honored to serve as the next CEO of Kilroy,” said Ms. Aman. “John and the leadership team have built a tremendous portfolio of high-quality assets over many years of prudent and thoughtful capital allocation. As a result, Kilroy is exceptionally well positioned for continued success and industry leadership in the years to come. I look forward to working alongside the incredibly talented Kilroy team, as we continue to identify new opportunities for growth while maintaining the Company’s commitment to innovation, wellness and sustainability, and financial discipline.”

Dr. Brennan added, “John is a true visionary in our industry and on behalf of the entire Board, I would like to thank him for his invaluable contributions to Kilroy during the past nearly 30 years as CEO.”

About Kilroy Realty Corporation

Kilroy Realty Corporation (NYSE: KRC, the “company”, “Kilroy”) is a leading U.S. landlord and developer, with operations in San Diego, Greater Los Angeles, the San Francisco Bay Area, the Pacific Northwest and Austin, Texas. The company has earned global recognition for sustainability, building operations, innovation and design. As pioneers and innovators in the creation of a more sustainable real estate industry, the company’s approach to modern business environments helps drive creativity and productivity for some of the world’s leading technology, entertainment, life science and business services companies.

The company is a publicly traded real estate investment trust (“REIT”) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring and managing office, life science and mixed-use projects.

As of September 30, 2023, Kilroy’s stabilized portfolio totaled approximately 16.3 million square feet of primarily office and life science space that was 86.2% occupied and 87.5% leased. The company also had more than 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.7%. In addition, the company had two in-process life science redevelopment projects with total estimated redevelopment costs of $80.0 million, totaling approximately 100,000 square feet, and two in-process development projects with an estimated total investment of $1.6 billion, totaling approximately 1.6 million square feet of office and life science space. The in-process development and redevelopment office and life science space is 32% leased.